| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80053 |
Comprehensive metabolic panel |
12,351 |
10,618 |
$1.48M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18,930 |
17,660 |
$856K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,541 |
2,439 |
$557K |
| 81001 |
|
8,850 |
8,083 |
$487K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,073 |
3,848 |
$430K |
| J3490 |
Unclassified drugs |
3,958 |
2,389 |
$350K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
6,680 |
3,698 |
$341K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,768 |
2,451 |
$318K |
| 87070 |
|
2,793 |
2,739 |
$290K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,834 |
10,802 |
$184K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,331 |
3,478 |
$178K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,748 |
1,688 |
$160K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
694 |
678 |
$157K |
| 81003 |
|
2,076 |
1,972 |
$117K |
| 82962 |
|
2,520 |
1,435 |
$107K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,362 |
2,198 |
$97K |
| 81025 |
|
5,119 |
4,825 |
$95K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,310 |
2,981 |
$81K |
| 71046 |
Radiologic examination, chest; 2 views |
1,881 |
1,784 |
$59K |
| 71045 |
Radiologic examination, chest; single view |
4,696 |
4,255 |
$59K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,019 |
3,494 |
$42K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
443 |
364 |
$40K |
| 80306 |
|
983 |
922 |
$38K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,350 |
4,794 |
$32K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,331 |
4,788 |
$31K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,045 |
2,992 |
$30K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,668 |
1,579 |
$28K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,420 |
12,951 |
$27K |
| A9150 |
Non-prescription drugs |
1,370 |
987 |
$26K |
| 73610 |
|
203 |
194 |
$23K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,033 |
916 |
$19K |
| J2704 |
Injection, propofol, 10 mg |
1,353 |
1,255 |
$18K |
| 73562 |
|
233 |
204 |
$18K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
24 |
12 |
$16K |
| 84702 |
|
1,007 |
869 |
$12K |
| 87807 |
|
1,091 |
1,063 |
$10K |
| 73630 |
|
183 |
170 |
$10K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,060 |
2,548 |
$10K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,515 |
4,765 |
$9K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,563 |
1,500 |
$8K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,109 |
1,044 |
$7K |
| 73030 |
|
90 |
80 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,627 |
3,962 |
$6K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,383 |
1,140 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,029 |
1,949 |
$6K |
| 94664 |
|
1,122 |
1,032 |
$5K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
300 |
278 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
360 |
351 |
$4K |
| 87088 |
|
3,663 |
3,422 |
$3K |
| 87210 |
|
112 |
107 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,940 |
2,420 |
$2K |
| 96376 |
|
413 |
302 |
$2K |
| 74018 |
|
42 |
40 |
$2K |
| 83735 |
|
1,736 |
1,347 |
$2K |
| 87186 |
|
1,343 |
1,242 |
$2K |
| 73130 |
|
14 |
12 |
$2K |
| 85379 |
|
659 |
615 |
$2K |
| 72100 |
|
55 |
50 |
$2K |
| 84484 |
|
3,365 |
2,622 |
$1K |
| 87077 |
|
1,318 |
1,220 |
$1K |
| 73110 |
|
14 |
13 |
$1K |
| 0001A |
|
31 |
26 |
$1K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
15 |
14 |
$1K |
| 0002A |
|
23 |
18 |
$791.09 |
| 83690 |
|
2,890 |
2,636 |
$725.03 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
428 |
387 |
$708.04 |
| 84443 |
Thyroid stimulating hormone (TSH) |
492 |
473 |
$606.39 |
| 85610 |
|
2,026 |
1,814 |
$541.41 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,659 |
1,372 |
$495.83 |
| 83880 |
|
835 |
744 |
$476.25 |
| 86850 |
|
262 |
241 |
$473.54 |
| 83605 |
|
1,125 |
972 |
$470.68 |
| 74022 |
|
12 |
12 |
$456.57 |
| 87040 |
|
841 |
506 |
$451.47 |
| 73502 |
|
13 |
12 |
$436.70 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,981 |
3,482 |
$414.39 |
| 84156 |
|
59 |
55 |
$396.43 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
734 |
687 |
$384.48 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
103 |
94 |
$380.28 |
| 59025 |
Fetal non-stress test |
176 |
147 |
$341.60 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
52 |
52 |
$290.24 |
| 93976 |
|
203 |
198 |
$229.64 |
| 71250 |
|
13 |
12 |
$200.65 |
| 84703 |
|
70 |
69 |
$195.74 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
240 |
231 |
$142.50 |
| 82550 |
|
534 |
457 |
$115.03 |
| 82150 |
|
70 |
64 |
$112.28 |
| 86900 |
|
1,122 |
1,069 |
$87.15 |
| 86901 |
|
1,241 |
1,179 |
$69.14 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,816 |
2,561 |
$67.44 |
| 80061 |
Lipid panel |
14 |
13 |
$53.12 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,500 |
1,358 |
$42.38 |
| A9270 |
Non-covered item or service |
157 |
110 |
$34.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,178 |
1,122 |
$25.48 |
| 82570 |
|
71 |
63 |
$18.24 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
767 |
641 |
$16.31 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
24 |
24 |
$11.61 |
| 85730 |
|
824 |
741 |
$8.10 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
354 |
344 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
134 |
133 |
$0.00 |
| 85027 |
|
13 |
12 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
72 |
65 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
57 |
51 |
$0.00 |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
15 |
15 |
$0.00 |
| 76801 |
|
109 |
101 |
$0.00 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
32 |
29 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
39 |
38 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
12 |
$0.00 |
| 87147 |
|
16 |
15 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
41 |
31 |
$0.00 |
| 86140 |
|
41 |
36 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
12 |
12 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
38 |
38 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,522 |
1,298 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
422 |
403 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
31 |
24 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
78 |
67 |
$0.00 |
| 84550 |
|
53 |
48 |
$0.00 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
78 |
71 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
32 |
28 |
$0.00 |
| 82805 |
|
13 |
12 |
$0.00 |